Related references
Note: Only part of the references are listed.Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
The emerging roles of tumor-derived exosomes in hematological malignancies
M. Boyiadzis et al.
LEUKEMIA (2017)
Exosomes Isolated from Ascites of T-cell Lymphoma-Bearing Mice Expressing Surface CD24 and HSP-90 Induce a Tumor-Specific Immune Response
Florencia Menay et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Ag-Presenting CpG-Activated pDCs Prime Th17 Cells That Induce Tumor Regression
Leslie Guery et al.
CANCER RESEARCH (2014)
Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity
Manjunatha Ankathatti Munegowda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Chemokine-Containing Exosomes Are Released from Heat-Stressed Tumor Cells via Lipid Raft-Dependent Pathway and Act as Efficient Tumor Vaccine
Taoyong Chen et al.
JOURNAL OF IMMUNOLOGY (2011)
Induction of Th17 Cells in the Tumor Microenvironment Improves Survival in a Murine Model of Pancreatic Cancer
Jennifer L. Gnerlich et al.
JOURNAL OF IMMUNOLOGY (2010)
MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models
Jung-ah Cho et al.
CANCER LETTERS (2009)
Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens
Meredith M. Curtis et al.
IMMUNOLOGY (2009)
Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα
Sophie Viaud et al.
PLOS ONE (2009)
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski et al.
BLOOD (2008)
Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer
Shengming Dai et al.
MOLECULAR THERAPY (2008)
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer
Timothy Kottke et al.
CANCER RESEARCH (2007)
Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes
Fangming Xiu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells
Yunshan Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8+ CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells
Shengming Dai et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes
Roberta Valenti et al.
CANCER RESEARCH (2006)
Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells
Weilin Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells
SM Dai et al.
CLINICAL CANCER RESEARCH (2005)
Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12
S Homma et al.
IMMUNOLOGY (2005)
Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells
MH Zhang et al.
NATURE IMMUNOLOGY (2004)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
Share Paper
